What are the suitable populations for Balversa?

Balversa is a new target anti-cancer star, specializing in FGFR-positive cancers, providing patients with precision treatment options, although effective, it is necessary to pay attention to side effects and must be used under the guidance of a doctor.

What are the suitable populations for Balversa?

The suitable population of Balversa mainly includes the following two categories:

1. Cancer patients with specific FGFR gene mutations

As a targeted therapy drug, Balversa is especially suitable for cancer patients who have been confirmed to carry FGFR2 or FGFR3 gene mutations by genetic testing, such as urothelial carcinoma.

2. Cancer patients who do not respond well to conventional chemotherapy

For some people with cancer, conventional chemotherapy may not respond well or become resistant to it. Balversa offers a new treatment option for these patients, especially those who have continued disease progression or relapse after first-line platinum-based chemotherapy.

While Balversa brings hope to specific patients, what should patients pay attention to when taking the drug in order to ensure efficacy and safety? Next, we will answer them one by one.

Precautions for Balversa

Considerations for Balversa include:

1. Monitor for adverse reactions

During the medication, it is necessary to pay close attention to the patient's physical condition, especially the digestive system reaction and electrolyte abnormalities, such as nausea, vomiting, diarrhea, and hyperkalemia, and take corresponding measures in time.

2. Avoid interacting with other medications

Balversa may interact with other medications, and your doctor should be informed of all medications you are taking before use to avoid potential risks.

Understanding the dos and don'ts of Balversa is critical to safe administration. In addition, for special populations, such as the elderly, pregnant women, etc., their medication needs to be more cautious. Next, we will delve into the use of Balversa in special populations.

Balversa is used in special populations

The use of Balversa in special populations should pay special attention to the following two points:

1. Pregnant and lactating women

Balversa may cause adverse effects on the embryo or fetus and should be avoided by pregnant women. Breastfeeding women should stop breastfeeding while using Balversa to prevent the drug from affecting the baby through breast milk.

2. Patients with liver and kidney insufficiency

For patients with hepatic and renal insufficiency, the metabolism and excretion of Balversa may be affected, and the dose should be adjusted according to the specific situation of the patient, and the relevant indicators should be closely monitored to ensure the safety of the drug.

【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.